Question 1

What is Bevacizumab?

Accepted Answer

Bevacizumab belongs to a class of medications known as angiogenesis inhibitors. It works by targeting and blocking a specific protein in the body called vascular endothelial growth factor (VEGF).

By inhibiting this protein, the medication helps prevent the formation of new blood vessels that tumors need to grow and spread. This process is intended to slow or stop the progression of certain cancerous growths.

Question 2

What is Bevacizumab used for?

Accepted Answer

Bevacizumab is used to treat:

colorectal cancer

non-small cell lung cancer

glioblastoma

and others

Question 3

How does Bevacizumab work?

Accepted Answer

Mechanism of Action

Bevacizumab belongs to a class of drugs known as angiogenesis inhibitors. It is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific target in the body.

The primary target of bevacizumab is a protein called vascular endothelial growth factor (VEGF). In a healthy body, VEGF helps create new blood vessels. However, many types of cancer cells produce high amounts of VEGF to encourage the growth of new blood vessels toward a tumor. This process, called angiogenesis, provides the tumor with the oxygen and nutrients it needs to grow and spread to other parts of the body.

How It Works Against Tumors

Bevacizumab works by interfering with the tumor's blood supply through the following steps:

Binding to VEGF: The drug circulates in the bloodstream and attaches itself to the VEGF proteins.

Blocking the Signal: By binding to VEGF, bevacizumab prevents the protein from connecting with the receptors on the surface of blood vessel cells.

Starving the Tumor: When the VEGF signal is blocked, the growth of new blood vessels is inhibited. This can cause existing small blood vessels in the tumor to shrink or disappear, effectively starving the tumor of its nutrient supply.

By limiting the blood supply, bevacizumab helps to slow the growth of the cancer and may make the tumor more vulnerable to other treatments, such as chemotherapy.

Question 4

What are the brand names for Bevacizumab?

Accepted Answer

Bevacizumab is sold under the brand name Avastin .

Question 5

What are the active ingredients in Bevacizumab?

Accepted Answer

The active ingredient in Bevacizumab is bevacizumab .

Question 6

What are the side effects of Bevacizumab?

Accepted Answer

Common side effects of Bevacizumab may include:

fatigue

headache

hypertension

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Bevacizumab?

Accepted Answer

Bevacizumab belongs to the monoclonal antibody VEGF inhibitor drug class.

Question 8

What is the dosage of Bevacizumab and how do I take it?

Accepted Answer

Administration Method

Bevacizumab is given as an infusion into a vein (intravenous). This procedure is performed by a healthcare professional in a clinical setting, such as a hospital or infusion center.

Dosing Schedule

The frequency of treatments depends on the specific condition being treated and how the body responds to the medication. It is commonly administered once every two weeks or once every three weeks.

Infusion Duration

The time required for each infusion may change over the course of treatment:

First dose: Usually administered slowly over a period of 90 minutes to monitor for any immediate reactions.

Second dose: If the first infusion was well-tolerated, the second dose may be given over 60 minutes.

Subsequent doses: If previous infusions were tolerated without issues, following doses may be administered over 30 minutes.

Missed Doses

Because this medication is administered on a specific schedule by a healthcare provider, it is important to keep all scheduled appointments. If an appointment is missed, contact your doctor or clinic immediately to reschedule the infusion.

Question 9

Is Bevacizumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Bevacizumab may cause birth defects or the loss of a pregnancy. Healthcare providers typically advise using effective birth control during treatment and for at least 6 months after the final dose. If a person becomes pregnant while using this medication, they should contact their doctor immediately to discuss the potential risks to the fetus.

Fertility

This medication may affect the function of the ovaries, which could impact a woman's ability to have children. It is not fully known if these effects on fertility are permanent.

Breastfeeding

It is not known whether bevacizumab passes into breast milk. Due to the risk of serious side effects in a nursing infant, breastfeeding is generally not recommended during treatment and for at least 6 months following the last dose.

Question 10

What forms and strengths does Bevacizumab come in?

Accepted Answer

Bevacizumab is available in the following form:

Injectable solution: This medication is a sterile, preservative-free liquid solution. It is supplied in single-dose vials for intravenous use.

This medication is a concentrated solution that must be diluted by a healthcare provider before it is administered. It is given as an infusion into a vein and is not available in oral forms such as tablets or capsules.

Question 11

What is the FDA approval status of Bevacizumab?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) has approved bevacizumab for the treatment of several specific conditions, typically in combination with other chemotherapy drugs. These include:

Metastatic colorectal cancer

Non-small cell lung cancer

Glioblastoma (a type of brain cancer)

Metastatic renal cell carcinoma (kidney cancer)

Cervical cancer

Epithelial ovarian, fallopian tube, or primary peritoneal cancer

Hepatocellular carcinoma (liver cancer)

Boxed Warning

Bevacizumab carries a boxed warning, which is the FDA’s most serious warning for a medication. This warning highlights the following risks:

Gastrointestinal Perforation: The drug can cause holes to develop in the stomach or intestines, which can be fatal.

Surgery and Wound Healing Complications: Bevacizumab can interfere with the body's ability to heal wounds. It should not be used for a certain period before or after elective surgery.

Hemorrhage: There is an increased risk of severe or fatal bleeding, including coughing up blood or bleeding in the brain.

Biosimilar Availability

The FDA has also approved several biosimilar versions of bevacizumab. A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product.

Question 12

What should I know about Bevacizumab and cost?

Accepted Answer

Several factors determine the total expense of bevacizumab therapy:

Product Selection: Bevacizumab is available as a reference biologic and as several biosimilars. Biosimilars are typically less expensive than the original brand-name medication.

Dosage and Frequency: The amount of medication needed is often based on the patient's weight and the specific condition being treated, which directly impacts the price per session.

Administration Fees: Since bevacizumab must be administered by a healthcare professional via intravenous (IV) infusion, the total cost includes charges for the clinical facility, medical supplies, and professional services.

Most health insurance plans cover bevacizumab for FDA-approved indications, though many require prior authorization. Out-of-pocket costs such as deductibles, copayments, or coinsurance will vary depending on the individual's insurance policy.

For patients facing high costs, financial assistance may be available through manufacturer-sponsored programs or independent charitable foundations. These programs often help eligible patients with medication costs or insurance copays.

Bevacizumab

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?